Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
It’s About Health Care, Not Health Insurance
|
Norm Wu |
09/28/09 |
Seattle
|
|
ConforMIS Shapes Corporate Expansion with $50M D Round
|
Ryan McBride |
07/13/09 |
Boston
|
|
KaloBios Gets $12M Genzyme, Baxter
|
Luke Timmerman |
12/22/08 |
Boston
|
|
Alder Gets Early Christmas Present: FDA Slaps Down Its Rival, Roche
|
Luke Timmerman |
12/08/08 |
Seattle
|
|
Korean Biotech Opens Mass. Office
|
Ryan McBride |
12/04/08 |
Boston
|
|
CombinatoRx Cuts 30 More Jobs, Wiping out Two-Thirds of Staff in Last Month
|
Luke Timmerman |
11/20/08 |
Boston
|
|
Oral Pill May Make Tough-to-Deliver RNAi Drugs Go Down Easy, RXi Says
|
Luke Timmerman |
11/13/08 |
Boston
|
|
CombinatoRx Cuts 45 Percent of Staff After Arthritis Drug Failure
|
Luke Timmerman |
11/04/08 |
Boston
|
|
Trubion Shares Leap, Drop, Leap Again After Encouraging Clinical Trial News
|
Luke Timmerman |
10/27/08 |
Seattle
|
|
ZymoGenetics Drug Trial Halted Because of Infection Risk
|
Luke Timmerman |
10/27/08 |
Seattle
|
|
ZymoGenetics Gets $21M From Bristol-Myers To Settle Patent Suit
|
Luke Timmerman |
10/23/08 |
Seattle
|
|
CombinatoRx Reckoning Arrives: Stock Crashes on Failed Arthritis Trial
|
Luke Timmerman |
10/06/08 |
Boston
|
|
CombinatoRx Judgment Day Coming Soon, Arthritis Drug Results On the Way
|
Luke Timmerman |
09/30/08 |
Boston
|
|
Ariad Loses Patent Case Against Amgen
|
Luke Timmerman |
09/22/08 |
Boston
|
|
Alder Sets Stage for Showdown With Roche, With “Fast Follower” Antibody Drug Strategy
|
Luke Timmerman |
09/18/08 |
Seattle
|
|
Trubion Pushing Forward Arthritis Trials, Working to Re-Ignite the Spark for Investors
|
Luke Timmerman |
08/26/08 |
Seattle
|
|
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge
|
Luke Timmerman |
08/14/08 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
